Galectin Therapeutics reported $-8520000 in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 3179M 2413M
Array Technologies Inc ARRY:US -25552000 25.54M
Bristol Myers Squibb BMY:US $ 1546M 491M
Galectin Therapeutics GALT:US $ -8.52M 0.07M
Gilead Sciences GILD:US $ 2592M 1070M
Idera Pharmaceuticals IDRA:US $ -5.96M 1.6M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Merk MRK:US $ 4567M 3022M
YTE INCY:US $ 181.74M 32.28M